Bell Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Sell |
182,228
-1,972
| -1% | -$107K | 0.43% | 39 |
|
|
2025
Q4 | $9.03M | Sell |
184,200
-8,681
| -5% | -$405K | 0.39% | 43 |
|
|
2025
Q3 | $8.32M | Buy |
192,881
+6,115
| +3% | +$239K | 0.36% | 45 |
|
|
2025
Q2 | $7.17M | Sell |
186,766
-8,316
| -4% | -$318K | 0.33% | 46 |
|
|
2025
Q1 | $7.56M | Buy |
195,082
+13,569
| +7% | +$497K | 0.41% | 42 |
|
|
2024
Q4 | $6.14M | Buy |
181,513
+30,602
| +20% | +$1.1M | 0.46% | 44 |
|
|
2024
Q3 | $6.17M | Sell |
150,911
-24,678
| -14% | -$1.01M | 0.73% | 39 |
|
|
2024
Q2 | $6.76M | Sell |
175,589
-171
| -0.1% | -$7.19K | 0.57% | 36 |
|
|
2024
Q1 | $7.53M | Buy |
175,760
+396
| +0.2% | +$16.3K | 0.65% | 34 |
|
|
2023
Q4 | $6.5M | Buy |
175,364
+1,790
| +1% | +$64.3K | 0.63% | 36 |
|
|
2023
Q3 | $6.29M | Sell |
173,574
-1,945
| -1% | -$69K | 0.69% | 32 |
|
|
2023
Q2 | $6.26M | Sell |
175,519
-11,541
| -6% | -$414K | 0.66% | 35 |
|
|
2023
Q1 | $6.66M | Buy |
187,060
+26,356
| +16% | +$922K | 0.7% | 37 |
|
|
2022
Q4 | $5.65M | Sell |
160,704
-21,362
| -12% | -$712K | 0.66% | 36 |
|
|
2022
Q3 | $5.36M | Buy |
182,066
+36,959
| +25% | +$1.4M | 0.69% | 36 |
|
|
2022
Q2 | $7.9M | Buy |
145,107
+10,145
| +8% | +$560K | 0.95% | 19 |
|
|
2022
Q1 | $7.35M | Buy |
134,962
+20,899
| +18% | +$1.14M | 0.82% | 25 |
|
|
2021
Q4 | $6.29M | Buy |
114,063
+20,081
| +21% | +$1.04M | 0.72% | 24 |
|
|
2021
Q3 | $4.49M | Buy |
93,982
+6,901
| +8% | +$347K | 0.56% | 38 |
|
|
2021
Q2 | $4.33M | Buy |
87,081
+9,006
| +12% | +$433K | 0.57% | 35 |
|
|
2021
Q1 | $3.48M | Buy |
78,075
+8,728
| +13% | +$396K | 0.5% | 42 |
|
|
2020
Q4 | $3.19M | Buy |
69,347
+18,713
| +37% | +$860K | 0.49% | 36 |
|
|
2020
Q3 | $2.38M | Sell |
50,634
-1,959
| -4% | -$98.2K | 0.42% | 43 |
|
|
2020
Q2 | $2.68M | Sell |
52,593
-18,085
| -26% | -$928K | 0.5% | 30 |
|
|
2020
Q1 | $3.35M | Buy |
70,678
+790
| +1% | +$42.1K | 0.73% | 18 |
|
|
2019
Q4 | $4.11M | Sell |
69,888
-291
| -0.4% | -$16.2K | 0.74% | 17 |
|
|
2019
Q3 | $3.74M | Buy |
70,179
+519
| +0.7% | +$26.7K | 0.71% | 16 |
|
|
2019
Q2 | $3.48M | Buy |
69,660
+456
| +0.7% | +$22.9K | 0.78% | 15 |
|
|
2019
Q1 | $3.62M | Buy |
69,204
+34,890
| +102% | +$1.74M | 0.97% | 12 |
|
|
2018
Q4 | $1.64M | Sell |
34,314
-68
| -0.2% | -$3.35K | 0.5% | 39 |
|
|
2018
Q3 | $1.73M | Sell |
34,382
-1,445
| -4% | -$73.4K | 0.53% | 42 |
|
|
2018
Q2 | $1.8M | Sell |
35,827
-1,161
| -3% | -$58.5K | 0.56% | 42 |
|
|
2018
Q1 | $1.81M | Buy |
36,988
+1,228
| +3% | +$57.2K | 0.58% | 44 |
|
|
2017
Q4 | $1.59M | Sell |
35,760
-5,790
| -14% | -$267K | 0.45% | 49 |
|
|
2017
Q3 | $2.11M | Buy |
41,550
+379
| +0.9% | +$19.2K | 0.61% | 39 |
|
|
2017
Q2 | $2.22M | Sell |
41,171
-959
| -2% | -$51.1K | 0.79% | 40 |
|
|
2017
Q1 | $2.22M | Buy |
42,130
+6,422
| +18% | +$326K | 0.83% | 35 |
|
|
2016
Q4 | $1.72M | Buy |
35,708
+2,350
| +7% | +$116K | 0.67% | 43 |
|
|
2016
Q3 | $1.8M | Buy |
+33,358
| New | +$1.83M | 1.13% | 39 |
|
|
2015
Q4 | – | Sell |
-25,428
| Closed | -$1.22M | – | 136 |
|
|
2015
Q3 | $1.22M | Sell |
25,428
-4,368
| -15% | -$227K | 0.97% | 25 |
|
|
2015
Q2 | $1.55M | Sell |
29,796
-837
| -3% | -$47.1K | 1.15% | 16 |
|
|
2015
Q1 | $1.77M | Buy |
30,633
+655
| +2% | +$37.6K | 1.24% | 13 |
|
|
2014
Q4 | $1.6M | Buy |
29,978
+13,136
| +78% | +$735K | 1.1% | 15 |
|
|
2014
Q3 | $968K | Buy |
16,842
+1,809
| +12% | +$111K | 0.69% | 43 |
|
|
2014
Q2 | $1M | Buy |
15,033
+724
| +5% | +$49K | 0.71% | 37 |
|
|
2014
Q1 | $956K | Sell |
14,309
-1,842
| -11% | -$125K | 0.64% | 42 |
|
|
2013
Q4 | $1.08M | Sell |
16,151
-2,024
| -11% | -$131K | 0.56% | 53 |
|
|
2013
Q3 | $1.14M | Sell |
18,175
-232
| -1% | -$14.9K | 0.4% | 98 |
|
|
2013
Q2 | $1.15M | Buy |
+18,407
| New | +$1.17M | 0.4% | 100 |
|
Other funds holding GSK
JEST
